Why is Mangalam Drugs falling/rising?

As of 19-Nov, Mangalam Drugs and Organics Ltd is experiencing a decline in its stock price, currently at Rs. 54.61, which represents a decrease of Rs. 6.53 or 10.68%. The stock has hit a new 52-week low of Rs. 54.01 today and has underperformed its sector by 10.75%. It has been on a downward trend for the last two days, with a total decline of 11.63% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent bearish sentiment. There is also a notable decrease in investor participation, with delivery volume falling by 5.03% compared to the 5-day average, suggesting reduced interest from investors. In the broader market context, Mangalam Drugs has significantly underperformed compared to the Sensex, with a 1-week return of -11.92% against the benchmark's gain of 0.85%. Over the past month, the stock has dropped 22.41%, while the Sensex has risen by 1.47%. This stark contrast highlights the stock's struggles relative to the overall market performance. The lack of available positive factors further compounds the negative sentiment surrounding the stock, contributing to its ongoing decline.